Ductal Carcinoma In Situ of the breast in younger women: A subgroup of patients at high risk

European Journal of Surgical Oncology

Volumn 36, Issue 12, 2010, Pages 1165-1171

  Tunon De Lara, C ^a   Lemanski, C ^b   Cohen Solal Le Nir, C ^c   De Lafontan, B ^d   Charra Brunaud, C ^e   Gonzague Casabianca, L ^f   Mignotte, H ^g   Fondrinier, E ^h   Giard, S ⁱ   Quetin, P ^j   Auvray, H ^k   Cutuli, B ^l  

^a INSTITUT BERGONIÉ   (France)

^b CENTRE VAL D AURELLE   (France)

^c Rene Huguenin Centre   (France)

^d INSTITUT CLAUDIUS REGAUD   (France)

^e Alexis Vautrin Cancer Centre   (France)

^f INSTITUT PAOLI CALMETTES   (France)

^g CENTRE LÉON BÉRARD   (France)

^h CENTRE PAUL PAPIN   (France)

ⁱ Oscar Lambret Centre   (France)

^j Regional Paul Strauss Cancer Centre   (France)

^k Jean Perrin Comprehensive Cancer Centre   (France)

^l Polyclinique de Courlancy   (France)

more..

Author keywords

Breast and cancer survival; Comedocarcinoma; Ductal carcinoma in situ; Local recurrence; Margin status; Radiation therapy; Relapse; Surgery; Young age

Indexed keywords

ADULT; ARTICLE; BREAST NECROSIS; CANCER CENTER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; WOMEN'S HEALTH; ADJUVANT THERAPY; AGE; BREAST TUMOR; CARCINOMA IN SITU; CLINICAL TRIAL; FRANCE; KAPLAN MEIER METHOD; MULTICENTER STUDY; PAGET NIPPLE DISEASE; PATIENT CARE; PREDICTIVE VALUE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SEGMENTAL MASTECTOMY; TUMOR RECURRENCE;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; KAPLAN-MEIER ESTIMATE; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; PATIENT CARE TEAM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; RISK FACTORS;

EID: 79952065951     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.09.001     Document Type: Article

References (31)

1. Cutuli B, Cottu PH, Guastalla JP, et al. A French national survey on infiltrating breast cancer: analysis of clinico-pathological features and treatment modalities in 1159 patients. Breast Cancer Res Treat 2006;95:55-64. (Pubitemid 43228081)
2. Allegra CJ, Aberle DR, Ganschow P, et al. National Institutes of Health State-of-the-Science Conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009. J Natl Cancer Inst 2010;102:161-9.
3. Virnig BA, Tuttle TM, Shamliyan T, et al. Ductal carcinoma in situ of the breast: a Systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 2010;102:170-8.
4. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinomain- situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263-71. (Pubitemid 32366979)
5. Schouten van der Velden AP, Peeters PH, Koot VC, et al. Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age. Ann Surg Oncol 2006; 13:990-8.
6. Solin LJ, Fourquet A, Vicini FA, et al. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 2005;103: 1137-46. (Pubitemid 40328083)
7. Van Zee KJ, Liberman L, Samli B, et al. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age. Cancer 1999;86:1757-67. (Pubitemid 29513045)
8. Cutuli B, Cohen-Solal-le-Nir C, de-Lafontan B, et al. Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience. Int J Radiat Oncol Biol Phys 2002;53: 868-79. (Pubitemid 34722631)
9. Bollet MA, Sigal-Zafrani B, Mazeau V, et al. Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first. Radiother Oncol 2007;82:272-80. (Pubitemid 46350796)
10. Schmidt RT, Tsangaris TN, Cheek JH. Breast cancer in women under 35 years of age. Am J Surg 1991;162:197-201.
11. Cutuli B, Fay R, Cohen-Solal-le-Nir C, et al. [Ductal carcinoma in situ of the breast. Analysis of 882 cases]. Presse Med 2004;33:83-9. (Pubitemid 38165888)
12. Tunon-de-Lara C, de Mascarel I, MacGrogan G, et al. Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatmentethe experience of one institute. Am J Clin Oncol 2001;24:531-6. (Pubitemid 33131410)
13. de Mascarel I, MacGrogan G, Mathoulin-Pelissier S, et al. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas. Cancer 2002;94:2134-42. (Pubitemid 34411969)
14. Cutuli B, Fourquet A, Luporsi E, et al. [Standards, Options and Recommendations for the management of ductal carcinoma in situ of the breast (DCIS): update 2004]. Bull Cancer 2005;92:155-68. (Pubitemid 40396123)
15. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006;24:3381-7. (Pubitemid 46638893)
16. Jhingran A, Kim JS, Buchholz TA, et al. Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: the University of Texas M.D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 2002;54:804-9.
17. Vicini FA, Kestin LL, Goldstein NS, et al. Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Clin Oncol 2000;18:296-306. (Pubitemid 30056418)
18. Fowble B, Hanlon AL, Fein DA, et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J Radiat Oncol Biol Phys 1997;38:949-57. (Pubitemid 27353673)
19. Kricker A, Goumas C, Armstrong B. Ductal carcinoma in situ of the breast, a population-based study of epidemiology and pathology. Br J Cancer 2004;90:1382-5. (Pubitemid 38586265)
20. Cutuli B, Cohen-Solal-le-Nir C, de Lafontan B, et al. Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients. Eur J Cancer 2001;37:2365-72. (Pubitemid 33097472)
21. Fisher ER, Land SR, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer 2004; 100:238-44. (Pubitemid 38063630)
22. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999;340:1455-61. (Pubitemid 29220544)
23. Turaka A, Freedman GM, Li T, et al. Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation. J Surg Oncol 2009;100:25-31.
24. Vicini FA, Recht A. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature. J Clin Oncol 2002;20:2736-44. (Pubitemid 34575647)
25. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor. Int J Radiat Oncol Biol Phys 1999;45:885-91. (Pubitemid 29525451)
26. Schwartz GF, Solin LJ, Olivotto IA, et al. The Consensus Conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999. Hum Pathol 2000;31:131-9. (Pubitemid 30090641)
27. Kaufmann M, Morrow M, von MG, et al. Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer 2010;116:1184-91.
28. Dunne C, Burke JP, Morrow M, et al. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 2009;27:1615-20.
29. Rodrigues NA, Dillon D, Carter D, et al. Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women. Cancer 2003;97:1393-403. (Pubitemid 36297768)
30. Omlin A, Amichetti M, Azria D, et al. Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol 2006;7:652-6. (Pubitemid 44143777)
31. Rudloff U, Brogi E, Reiner AS, et al. The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy. Ann Surg 2010;251:583-91.